| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $67.6M | +1.9% | +3.8% |
| Cost of Revenue | $26.9M | +2.9% | +4.0% |
| Gross Profit | $40.7M | +1.2% | +3.7% |
| R&D Expense | $12.1M | -3.2% | -15.0% |
| SG&A Expense | $8.2M | +6.4% | +1.1% |
| Operating Income | $1.3M | +41.0% | +156.5% |
| Pre-tax Income | $1.5M | +28.1% | +164.1% |
| Income Tax | $64K | +154.2% | -30.4% |
| Net Income | $1.4M | +11.0% | +158.9% |
| EPS (Basic) | $0.05 | +0.0% | +155.6% |
| EPS (Diluted) | $0.05 | +25.0% | +155.6% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $21.7M | +11.1% | +26.8% |
| Accounts Receivable | $8.8M | +2.5% | +7.3% |
| Inventory | $15.3M | +3.5% | +16.0% |
| Current Assets | $64.2M | +7.5% | +16.6% |
| Total Assets | $152.7M | +1.7% | +2.1% |
| Current Liabilities | $51.7M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.0M | — | — |
| Capital Expenditures | $4.0M | — | — |
| Investing Cash Flow | -$4.0M | — | — |
| Financing Cash Flow | -$9.1M | — | — |
| Free Cash Flow | $13.0M | — | — |
| +1.6% |
| Total Liabilities | $62.7M | +1.2% | -5.1% |
| Stockholders' Equity | $90.0M | +2.1% | +7.8% |